Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Total Revenue | 170.8M | 29.8M | 119.1M | 415.2M | -- |
| Operating Revenue | 170.8M | 29.8M | 119.1M | 415.2M | -- |
| Selling General And Administration | 3.3M | 3.6M | 11.4M | 4.3M | -- |
| General And Administrative Expense | 3.3M | 3.6M | 11.4M | 4.3M | -- |
| Operating Expense | 32.2M | 33.0M | 55.4M | 40.2M | -- |
| Interest Expense | -- | 9.5M | -- | 705,000 | 3.9M |
| Interest Income | 43.1M | 3.7M | 30.0M | 119.5M | -- |
| Net Interest Income | 43.1M | -5.8M | 30.0M | 118.8M | -- |
| Pretax Income | 138.5M | -3.2M | 63.7M | 375.0M | -- |
| Tax Provision | 16.5M | 180,000 | 11.3M | 44.8M | -- |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Net Income From Continuing Operation Net Minority Interest | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Net Income Including Noncontrolling Interests | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Net Income Common Stockholders | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Net Income | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Reconciled Depreciation | 1.4M | 1.3M | 1.2M | 1.1M | -- |
| Basic EPS | 8.47 | -0.23 | 3.48 | 21.93 | -- |
| Diluted EPS | 8.47 | -0.23 | 3.48 | 21.93 | -- |
| Basic Average Shares | 14.4M | 14.9M | 15.0M | 15.1M | -- |
| Diluted Average Shares | 14.4M | 14.9M | 15.0M | 15.1M | -- |
| Tax Rate For Calcs | 0.12 | 0.15 | 0.18 | 0.12 | -- |
| Normalized Income | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Diluted NI Availto Com Stockholders | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Net Income Continuous Operations | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 177.0M | 145.1M | 217.9M | 218.4M | -- |
| Cash Equivalents | 3.7M | 837,000 | 1.7M | 13.1M | -- |
| Cash Financial | 173.3M | 144.3M | 216.2M | 205.3M | -- |
| Receivables | 121.7M | 61.5M | 90.1M | 104.3M | -- |
| Gross PPE | 20.1M | 13.1M | 12.2M | 11.8M | -- |
| Accumulated Depreciation | -8.4M | -6.9M | -5.6M | -4.5M | -- |
| Net PPE | 11.7M | 6.1M | 6.6M | 7.3M | -- |
| Investments And Advances | 1.1B | 1.1B | 1.1B | 1.0B | -- |
| Long Term Equity Investment | 48.5M | 52.2M | 49.3M | 35.5M | -- |
| Total Assets | 1.4B | 1.3B | 1.4B | 1.4B | -- |
| Accounts Payable | 12.7M | 16.2M | 13.8M | 6.9M | -- |
| Payables | 15.2M | 16.2M | 39.0M | 7.2M | -- |
| Total Liabilities Net Minority Interest | 177.8M | 165.8M | 211.9M | 174.1M | -- |
| Common Stock | 76.0M | 78.8M | 80.6M | 80.8M | -- |
| Capital Stock | 76.0M | 78.8M | 80.6M | 80.8M | -- |
| Retained Earnings | 1.2B | 1.1B | 1.1B | 1.1B | -- |
| Common Stock Equity | 1.3B | 1.2B | 1.2B | 1.2B | -- |
| Stockholders Equity | 1.3B | 1.2B | 1.2B | 1.2B | -- |
| Total Equity Gross Minority Interest | 1.3B | 1.2B | 1.2B | 1.2B | -- |
| Net Tangible Assets | 1.3B | 1.2B | 1.2B | 1.2B | -- |
| Tangible Book Value | 1.3B | 1.2B | 1.2B | 1.2B | -- |
| Share Issued | 14.2M | 14.7M | 15.0M | 15.1M | -- |
| Ordinary Shares Number | 14.2M | 14.7M | 15.0M | 15.1M | -- |
| Available For Sale Securities | 82.0M | 104.9M | 61.7M | 130.4M | -- |
| Cash Cash Equivalents And Federal Funds Sold | 177.0M | 145.1M | 217.9M | 218.4M | -- |
| Derivative Product Liabilities | 18.1M | 2.6M | 7.1M | 0.00 | -- |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 979.6M | 950.9M | 1.0B | 849.1M | -- |
| Investmentin Financial Assets | 1.1B | 1.1B | 1.1B | 982.7M | -- |
| Other Payable | -- | -- | -- | -- | 26.0M |
| Taxes Receivable | 8.9M | 21.5M | 1.1M | 5.0M | -- |
| Total Tax Payable | 2.5M | 0.00 | 25.2M | 340,000 | -- |
| Line Item | FY 2025Mar 31, 2025 | FY 2024Mar 31, 2024 | FY 2023Mar 31, 2023 | FY 2022Mar 31, 2022 | FY 2021Mar 31, 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | 79.5M | -33.8M | 13.6M | 41.0M | -- |
| Depreciation And Amortization | 1.4M | 1.3M | 1.2M | 1.1M | -- |
| Change In Working Capital | -21.8M | -27.7M | 25.0M | -14.9M | -- |
| Change In Receivables | -18.4M | -2.4M | -5.3M | -20.7M | -- |
| Change In Payable | -7.1M | -22.8M | 31.8M | -2.3M | -- |
| Change In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Other Non Cash Items | -1.2M | -4.7M | 3.1M | 56.6M | -- |
| Capital Expenditure | -938,000 | -854,000 | -452,000 | -466,000 | -- |
| Purchase Of PPE | -938,000 | -854,000 | -452,000 | -466,000 | -- |
| Net PPE Purchase And Sale | -938,000 | -854,000 | -452,000 | -466,000 | -- |
| Investing Cash Flow | -938,000 | -854,000 | -452,000 | -466,000 | -- |
| Repurchase Of Capital Stock | -35.0M | -25.9M | -1.9M | -350,000 | -- |
| Net Common Stock Issuance | -35.0M | -25.9M | -1.9M | -350,000 | -- |
| Common Stock Dividend Paid | -11.7M | -12.2M | -11.8M | -8.6M | -- |
| Common Stock Payments | -35.0M | -25.9M | -1.9M | -350,000 | -- |
| Financing Cash Flow | -46.7M | -38.1M | -13.7M | -8.9M | -- |
| Changes In Cash | 31.8M | -72.7M | -547,000 | 31.6M | -- |
| Beginning Cash Position | 145.1M | 217.9M | 218.4M | 186.8M | -- |
| End Cash Position | 177.0M | 145.1M | 217.9M | 218.4M | -- |
| Free Cash Flow | 78.6M | -34.7M | 13.2M | 40.5M | -- |
| Cash Dividends Paid | -11.7M | -12.2M | -11.8M | -8.6M | -- |
| Change In Accrued Expense | 3.6M | -2.4M | -1.6M | 8.1M | -- |
| Depreciation | 1.4M | 1.3M | 1.2M | 1.1M | -- |
| Dividend Received Cfo | 15.1M | 36.0M | 0.00 | 82.6M | -- |
| Gain Loss On Investment Securities | 3.9M | -30.5M | -75.0M | -436.6M | -- |
| Net Income From Continuing Operations | 122.0M | -3.4M | 52.4M | 330.2M | -- |
| Net Other Financing Charges | 0.00 | 0.00 | 0.00 | 0.00 | -- |